Last reviewed · How we verify
Saccharine
Saccharine is a Small molecule drug developed by Maharashtra University of Health Sciences. It is currently in Phase 3 development. Also known as: Sugar free.
-
Baseline phase 3 → approval rate
+58.3pp
Industry-wide phase 3 drugs reach approval ~58.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2028–2030 | — |
| EMA | EU | 2029–2031 | +0.7 yr |
| MHRA | GB | 2029–2031 | +0.7 yr |
| Health Canada | CA | 2029–2032 | +0.9 yr |
| TGA | AU | 2029–2032 | +1.2 yr |
| PMDA | JP | 2029–2032 | +1.5 yr |
| NMPA | CN | 2030–2033 | +2.3 yr |
| MFDS | KR | 2029–2032 | +1.4 yr |
| CDSCO | IN | 2029–2033 | +1.8 yr |
| ANVISA | BR | 2030–2033 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Saccharine |
|---|---|
| Also known as | Sugar free |
| Sponsor | Maharashtra University of Health Sciences |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Efficacy Study of MsChief Personal Lubricant in Healthy Female Subjects (NA)
- Artificial Sweeteners in Breast Milk (NA)
- Microbiome and Non-caloric Sweeteners in Humans (NA)
- Effects of Low/No Calorie Sweeteners on Glucose Tolerance (NA)
- Transport of Artificial Sweeteners During Pregnancy (NA)
- Prefatory Study to Explore Changes in Nasal Mucociliary Clearance and to Standardize Nasal Scraping Procedure (NA)
- Assessing the Effect of Lettuce on Intestinal Water Content Through Magnetic Resonance Imaging of the Small Bowel (NA)
- Effects of Humidity (During CPAP Treatment) on Mucociliary Clearance in Patients With Obstructive Sleep Apnea (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Saccharine CI brief — competitive landscape report
- Saccharine updates RSS · CI watch RSS
- Maharashtra University of Health Sciences portfolio CI
Frequently asked questions about Saccharine
What is Saccharine?
Who makes Saccharine?
Is Saccharine also known as anything else?
What development phase is Saccharine in?
Related
- Manufacturer: Maharashtra University of Health Sciences — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: Sugar free
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing